Related content

Oral 17β-estradiol and sequential progesterone in menopause: Effects on insulin-like growth factors and their binding proteins

By Mozzanega Bruno   Babbo Gian Luca   Salmaso Luigi   De Toni Renzo   Schiavo Alessandra   Mioni Roberto   De Kreutzenberg Saula Vigili  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-01 ,pp. : 50-57

Informa Healthcare

Access to resources Recommend Favorite

Dose-dependent inhibition of mitochondrial ATP synthase by 17β-estradiol

By Massart F.   Paolini S.   Piscitelli E.   Brandi M. L.   Solaini G.  

Gynecological Endocrinology, Vol. 16, Iss. 5, 2002-10 ,pp. : 373-377

Informa Healthcare

Access to resources Recommend Favorite

Transforming growth factor-β1 modulates chondrocyte responsiveness to 17β-estradiol

By Nasatzky Erez   Grinfeld Dana   Boyan Barbara   Dean David   Ornoy Asher   Schwartz Zvi  

Endocrine Journal, Vol. 11, Iss. 3, 1999-12 ,pp. : 241-249

Humana Press, Inc

Access to resources Recommend Favorite

Conversion of circulating estrone sulfate to 17β-estradiol by ovarian tumor tissue: A possible mechanism behind elevated circulating concentrations of 17β-estradiol in postmenopausal women with ovarian tumors

By Kirilovas Dmitrijus   Schedvins Kjell   Naessén Tord   Von Schoultz Bo   Carlström Kjell  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-01 ,pp. : 25-28

Informa Healthcare

Access to resources Recommend Favorite

Efficacy on climacteric symptoms of a continuous combined regimen of 1mg 17β-estradiol and trimegestone versus two regimens containing 1 or 2mg 17β-estradiol and norethisterone acetate

By Gambacciani M   Spielmann D   Genazzani AR   Group The Trimegestone 301 Study  

Gynecological Endocrinology, Vol. 21, Iss. 2, 2005-08 ,pp. : 65-73

Informa Healthcare

Access to resources Recommend Favorite